Workflow
滴定仪
icon
Search documents
北交所科技成长产业跟踪第三十三期:中央财经委定调推进海洋经济高质量发展,关注北交所深海经济产业链企业
Hua Yuan Zheng Quan· 2025-07-07 08:58
证券研究报告 | 北交所定期报告 | | --- | hyzqdatemark 2025 年 07 月 07 日 证券分析师 赵昊 SAC:S1350524110004 zhaohao@huayuanstock.com 万枭 SAC:S1350524100001 wanxiao@huayuanstock.com 中央财经委定调推进海洋经济高质量发展,关注北交所深海经济产业链企业 ——北交所科技成长产业跟踪第三十三期(20250706) 投资要点: 风险提示:宏观经济环境变动风险、市场竞争风险、资料统计误差风险。 请务必仔细阅读正文之后的评级说明和重要声明 联系人 深海科技首次现身政府工作报告,2024 年全国海洋生产总值 10.54 万亿元(yoy+5.9%)。中共中央总 书记、国家主席、中央军委主席、中央财经委员会主任习近平于 2025 年 7 月 1 日上午主持召开中央财经 委员会第六次会议,研究纵深推进全国统一大市场建设、海洋经济高质量发展等问题。2025 年《政府工 作报告》提出"开展新技术新产品新场景大规模应用示范行动,推动商业航天、低空经济、深海科技等 新兴产业安全健康发展"。2024 年全国海洋 ...
科学仪器行业资讯周报(2025年6月23-29日)
仪器信息网· 2025-06-30 08:35
特别提示 微信机制调整,点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标,否则很可能无法看到我 们的推送。 2025年第26周(6月23日-29日)科学仪器行业小报,一文看尽行业大事: 政策与行业规范 · 四川省科研仪器共享政策落地 四川省科技厅等四部门于6月27日发布《四川省重大科研基础设施和大型科研仪器开放共享管 理办法》,要求将单台(套)价值50万元及以上的科学仪器纳入省级共享平台,并通过绩效考 核 机 制 推 动 资 源 高 效 利 用 。 政 策 明 确 管 理 单 位 需 建 立 在 线 服 务 平 台 并 公 示 收 费 标 准 , 将 于 2025年7月18日实施。 上海仪电・科学仪器于6月2 4 - 2 6日参加在上海举办的第二十三届世界制药原料中国展,展示了 符合制药行业GMP规范的滴定仪、水分仪、光谱色谱仪等检测设备,并提供3Q认证服务,覆 盖药品质量控制全流程。 · 工业检测设备智能化升级 卓茂科技于6月25日发布高速CT型X射线全自动检测设备AXI9000,解决传统2D检测无法切 层的痛点,适用于电子制造行业的3D缺陷检测。 厂商动态与新品发布 · 国产高端透射电镜突破国 ...
国际品牌、前沿会议与展位图大公开!仪器采购/研发/决策者必收~
仪器信息网· 2025-06-03 06:22
错过这次,你可能要再等 一年 ! 6月20日前 完成观众登记 免100元 现场门票费! PMEC China实验室仪器与装备展区 将于 2025年6月24-26日 在 上海新国际博览中心 盛大启 幕,以全新姿态于 W5、W11、W12馆 惊艳亮相。本次展会将汇聚超过 300家 国内外知名品 牌,其中国际品牌占比近 15% ,包括 Nouryon、BRAND、Daicel、康宁东曹、马尔文、安 东帕、瑞士万通、大昌华嘉、海道尔夫、LGC、沃申马洛、安捷伦、依拉勃、KNF 等众多实 验室领域的国际代表品牌标杆品牌都将悉数登场、同台竞技。 他们将携带各自的新产品和技术成果参展,从实验室常用设备到高端分析仪器,从生命科学仪器到 实验室建设及家具亮相展区,形成从基础保障到前沿突破的完整价值链,为参会者带来一场视觉与 技术的双重盛宴。 作为行业标杆平台,展会以" 智能、安全、精准 "为核心主题,通过创新展品矩阵与专业论坛的深 度融合,不仅展现实验室装备的技术演进方向,更将推动实验室建设向数字化、智能化和可持续化 方向转型升级,为行业高质量发展注入新动能。 助推实验室全链升级与智慧转型 大昌华嘉科学仪器 展位号:W5D02 ...
MTD Q1 Earnings Top Estimates, Sales Decline Y/Y, Shares Rise
ZACKS· 2025-05-05 15:35
Core Viewpoint - Mettler-Toledo International (MTD) reported strong first-quarter 2025 results, with a positive outlook driven by growth in the laboratory business and recent innovations, despite a year-over-year decline in earnings and sales [1][2]. Financial Performance - Adjusted earnings for Q1 2025 were $8.19 per share, exceeding the Zacks Consensus Estimate by 3.67%, although this represents a 7.9% decline year-over-year [1]. - Net sales reached $883.744 million, surpassing the Zacks Consensus Estimate by 1%, but declined 5% on a reported basis and 3% on a local currency basis compared to the previous year [2]. Segment Performance - MTD's revenues were categorized into three segments: Laboratory Instruments ($500 million, 56.6% of net sales), Industrial Instruments ($341 million, 38.6%), and Food Retail ($42 million, 4.8%) [3]. - The Laboratory and Industrial segments experienced a year-over-year decline of 3% and 1% respectively in local currency, while the Food Retail segment saw a 12% decrease [3]. Geographic Sales Breakdown - Sales distribution included $378 million (42.8%) from the Americas, $248 million (28.1%) from Europe, and $258 million (29.2%) from Asia/Rest of the World [4]. - Year-over-year sales in the Americas and Asia/Rest of the World declined by 1% and 2% respectively, while Europe experienced a 7% decline [4]. Operating Results - The gross margin improved to 59.6%, an increase of 40 basis points year-over-year [5]. - Research & development (R&D) expenses were $46.3 million, a slight decrease of 0.1% from the previous year, while selling, general & administrative (SG&A) expenses rose by 3.6% to $242.8 million [5]. - The adjusted operating margin was reported at 26.8%, down 210 basis points from the prior year [6]. Balance Sheet & Cash Flow - As of March 31, 2025, Mettler-Toledo had cash and cash equivalents of $64.291 million, an increase from $59.362 million at the end of 2024 [7]. - Long-term debt stood at $1.89 billion, with cash generated from operating activities at $194.5 million, down from $266.2 million in the previous quarter [7]. Future Guidance - For Q2 2025, Mettler-Toledo expects sales to increase by 0-1% in local currency compared to the previous year, with adjusted earnings projected between $9.45 and $9.70 per share, reflecting a growth rate of down 2% to up 1% [8]. - The Zacks Consensus Estimate for Q2 revenues is $949.6 million, indicating a year-over-year increase of 0.3%, while the consensus for earnings is $10.22 per share, representing a 5.91% increase from the previous year [9]. - For the full year 2025, Mettler-Toledo anticipates a sales increase of approximately 1% to 2% in local currency compared to 2024, with adjusted earnings expected between $41.25 and $42 per share, indicating 0-2% growth [10].
Mettler-Toledo(MTD) - 2025 Q1 - Earnings Call Transcript
2025-05-02 12:30
Mettler-Toledo International (MTD) Q1 2025 Earnings Call May 02, 2025 08:30 AM ET Speaker0 Good morning, ladies and gentlemen, and thank you for standing by. My name is Kelvin, and I will be your conference operator today. At this time, I would like to welcome everyone to the Mettler Toledo First Quarter twenty twenty five Earnings Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question and answer session. Thank you. I would now like to ...